Stockscreener 앱 받기
8.67
7.67%
-0.72
시간 외 거래:
8.67
전일 마감가:
$9.39
열려 있는:
$9.39
하루 거래량:
700.82K
Relative Volume:
1.77
시가총액:
$451.51M
수익:
-
순이익/손실:
$-19.90M
주가수익비율:
-16.36
EPS:
-0.53
순현금흐름:
$-19.80M
1주 성능:
-1.03%
1개월 성능:
+46.21%
6개월 성능:
+137.53%
1년 성능:
+61.15%
1일 변동 폭
$8.40
$9.52
1주일 범위
$8.40
$10.42
52주 변동 폭
$3.19
$10.42
Diamedica Therapeutics Inc Stock (DMAC) Company Profile
명칭
Diamedica Therapeutics Inc
전화
(763) 496-5454
주소
301 CARLSON PARKWAY, MINNEAPOLIS, MN
DMAC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DMAC
Diamedica Therapeutics Inc
|
8.67 | 489.01M | 0 | -19.90M | -19.80M | -0.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Diamedica Therapeutics Inc Stock (DMAC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-14 | 재개 | Cantor Fitzgerald | Overweight |
| 2025-10-30 | 개시 | TD Cowen | Buy |
| 2024-10-07 | 개시 | H.C. Wainwright | Buy |
| 2024-04-24 | 재개 | Craig Hallum | Buy |
| 2023-06-22 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-04-09 | 개시 | Oppenheimer | Outperform |
| 2021-02-17 | 개시 | ROTH Capital | Buy |
| 2020-10-30 | 개시 | Guggenheim | Buy |
| 2020-07-08 | 개시 | Maxim Group | Buy |
| 2019-04-30 | 개시 | Dougherty & Company | Buy |
| 2019-03-05 | 개시 | Lake Street | Buy |
모두보기
Diamedica Therapeutics Inc 주식(DMAC)의 최신 뉴스
DiaMedica Therapeutics (NASDAQ:DMAC) Trading Up 7.4%Here's Why - MarketBeat
Top investors say DiaMedica Therapeutics Inc (DMAC) ticks everything they need - setenews.com
DiaMedica Therapeutics (NASDAQ:DMAC) Sets New 1-Year HighTime to Buy? - MarketBeat
Analysts Offer Insights on Healthcare Companies: Staar Surgical (STAA) and Diamedica Therapeutics (DMAC) - The Globe and Mail
DiaMedica Therapeutics (NASDAQ:DMAC) Major Shareholder Jan Stahlberg Purchases 182,882 Shares of Stock - Defense World
DiaMedica Therapeutics (NASDAQ:DMAC) Major Shareholder Jan Stahlberg Buys 187,393 Shares of Stock - Defense World
Jan Stahlberg Acquires 208,872 Shares of DiaMedica Therapeutics (NASDAQ:DMAC) Stock - MarketBeat
DiaMedica Therapeutics (NASDAQ:DMAC) Major Shareholder Acquires $1,234,453.50 in Stock - MarketBeat
Insider Buying: DiaMedica Therapeutics (NASDAQ:DMAC) Major Shareholder Purchases 128,426 Shares of Stock - MarketBeat
What dividend safety score for DiaMedica Therapeutics Inc. stock2025 Risk Factors & Fast Gain Stock Tips - Newser
What drives DiaMedica Therapeutics Inc stock priceAnalyst Downgrades & Free Lightning Fast Capital Gains - earlytimes.in
We Think DiaMedica Therapeutics (NASDAQ:DMAC) Can Afford To Drive Business Growth - Yahoo Finance
Is DiaMedica Therapeutics Inc. stock in correction or buying zoneJuly 2025 Patterns & Fast Exit and Entry Trade Guides - moha.gov.vn
Private Capital's DiaMedica Therapeutics Inc(DMAC) Holding History - GuruFocus
Why DiaMedica Therapeutics Inc. stock is a value investor pickJuly 2025 Drop Watch & Smart Allocation Stock Tips - moha.gov.vn
There is no way DiaMedica Therapeutics Inc (DMAC) can keep these numbers up - setenews.com
Dir Parsons Acquires 12,000 Of DiaMedica Therapeutics Inc [DMAC] - TradingView
[Form 4] DiaMedica Therapeutics Inc. Insider Trading Activity - Stock Titan
DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
DiaMedica In Focus After 52-Week High And FDA Meeting Progress - RTTNews
How DiaMedica Therapeutics Inc. stock compares to industry benchmarksJuly 2025 Intraday Action & Verified Swing Trading Watchlists - newser.com
3 Biotech Stocks Wall Street Analysts Predict Will More Than Double - inkl
HC Wainwright Issues Pessimistic Forecast for DMAC Earnings - MarketBeat
HC Wainwright Has Bearish Forecast for DMAC FY2025 Earnings - Defense World
Smart tools for monitoring DiaMedica Therapeutics Inc.’s price actionPortfolio Value Summary & Growth Focused Stock Pick Reports - newser.com
Why analysts remain bullish on DiaMedica Therapeutics Inc. stock2025 Top Gainers & Fast Gaining Stock Reports - newser.com
Published on: 2025-11-19 22:42:15 - newser.com
Will DiaMedica Therapeutics Inc. stock return to pre crisis levels2025 Analyst Calls & Momentum Based Trading Signals - newser.com
Published on: 2025-11-19 13:58:17 - newser.com
Is DiaMedica Therapeutics Inc. stock supported by innovation pipelineTake Profit & Fast Momentum Entry Tips - newser.com
This trade activity should not be overlooked: DiaMedica Therapeutics Inc (DMAC) - setenews.com
Is DiaMedica Therapeutics Inc. still worth holding after the dip2025 Institutional Moves & Weekly Breakout Opportunity Watchlist - newser.com
What is HC Wainwright’s Estimate for DMAC Q1 Earnings? - Defense World
Published on: 2025-11-18 23:37:26 - newser.com
Can DiaMedica Therapeutics Inc. stock outperform in 2025 bull marketTrade Entry Summary & Fast Gaining Stock Strategy Reports - newser.com
Why DiaMedica Therapeutics Inc. stock remains on watchlistsRate Hike & Safe Swing Trade Setups - newser.com
Short interest data insights for DiaMedica Therapeutics Inc.2025 Biggest Moves & AI Powered Buy/Sell Recommendations - newser.com
DiaMedica Therapeutics (NASDAQ:DMAC) Lowered to "Sell" Rating by Wall Street Zen - MarketBeat
Has DiaMedica Therapeutics Inc. formed a bullish divergence2025 Price Momentum & Community Driven Trade Alerts - newser.com
Developing predictive dashboards with DiaMedica Therapeutics Inc. dataStop Loss & Fast Momentum Entry Tips - newser.com
DiaMedica Therapeutics Inc Stock Analysis and ForecastSector-Based Investing & Low Risk Trading Growth - earlytimes.in
What Futures Contracts Reveal About Globesecure Technologies Limiteds Near Term VolatilityUtilities Sector Analysis & Small Budget Investment Tips - earlytimes.in
Can DiaMedica Therapeutics Inc. stock double in next 5 yearsCEO Change & Stock Market Timing Techniques - newser.com
Diamedica Therapeutics Inc (DMAC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Diamedica Therapeutics Inc 주식 (DMAC) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| STAHLBERG JAN | 10% Owner |
Nov 21 '25 |
Buy |
7.41 |
208,872 |
1,547,574 |
8,712,390 |
| STAHLBERG JAN | 10% Owner |
Nov 18 '25 |
Buy |
6.75 |
182,882 |
1,234,618 |
8,134,740 |
| STAHLBERG JAN | 10% Owner |
Nov 17 '25 |
Buy |
6.52 |
187,393 |
1,221,165 |
7,951,858 |
| STAHLBERG JAN | 10% Owner |
Nov 20 '25 |
Buy |
7.41 |
128,426 |
951,213 |
8,503,518 |
| STAHLBERG JAN | 10% Owner |
Nov 25 '25 |
Buy |
8.57 |
73,099 |
626,817 |
8,825,742 |
| STAHLBERG JAN | 10% Owner |
Nov 24 '25 |
Buy |
7.89 |
40,253 |
317,721 |
8,752,643 |
| Parsons James T. | Director |
Nov 21 '25 |
Option Exercise |
2.20 |
12,000 |
26,400 |
87,854 |
| STAHLBERG JAN | 10% Owner |
Aug 25 '25 |
Buy |
6.00 |
338,265 |
2,029,252 |
7,654,045 |
| STAHLBERG JAN | 10% Owner |
Aug 13 '25 |
Buy |
5.91 |
293,601 |
1,734,918 |
7,058,066 |
| STAHLBERG JAN | 10% Owner |
Aug 14 '25 |
Buy |
5.99 |
70,414 |
421,921 |
7,128,480 |
0.36%
1.05%
자본화:
|
볼륨(24시간):